Search - tctmd.com

Displaying 1 - 20 of 91

Sort: Relevancy | Date

News Features

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Shelley Wood

December 30, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular News and Features for 2016

Shelley Wood

December 29, 2016

Presentation TCT 2016

Device Performance in Pre-Approval Studies vs Unrestricted Real-World Use: Lessons Learned and Future Opportunities

Presenter: Owen Faris, Mitchell W. Krucoff

October 31, 2016

Presentation TCT 2016

Key Note Lecture II. Regulatory Reform of Medical Device Approvals by the European Commission Motivating Factors, Anticipated Changes, and Timelines

Presenter: Matthew G. Hillebrenner, Gregg W. Stone, Alan G. Fraser

October 31, 2016

FDA Approves Amplatzer PFO Occluder for Prevention of Recurrent Stroke

News Daily News

La FDA Aprueba el Oclusor del FOP Amplatzer para la Prevención de ACV Recurrentes

Yael L. Maxwell

October 28, 2016

News Daily News

FDA 批准 PFO 封堵器用于预防中风复发

Yael L. Maxwell

October 28, 2016

News Daily News

FDA Approves Amplatzer PFO Occluder for Prevention of Recurrent Stroke

Yael L. Maxwell

October 28, 2016

News Industry News

Corindus Vascular Robotics Receives FDA Clearance for Next Generation Robotic System

October 27, 2016

News Daily News

FDA Approves 34-mm TAVR Valve for Patients With Larger Anatomy

L.A. McKeown

October 27, 2016

News Daily News

Sapien 3 Approved for Use in Intermediate-Risk Patients in Europe

Michael O'Riordan

September 20, 2016

News Daily News

FDA Expands Indications for Two Endovascular Stroke Therapies

Todd Neale

September 06, 2016

News Daily News

TAVR as an Option for Intermediate-Risk Patients: Physicians Respond

Yael L. Maxwell

August 24, 2016

News Daily News

Survival Better, No ‘Risk Creep’ for TAVR vs Surgery in Lower-Risk Patients

L.A. McKeown

August 24, 2016

News Daily News

FDA Declines to Approve Portola’s Reversal Agent for Factor Xa Inhibitors

Michael O'Riordan

August 18, 2016

News Daily News

FDA Approves Sapien XT and Sapien 3 for Intermediate-Risk Patients

Yael L. Maxwell

August 18, 2016

News Daily News

Next-Generation CoreValve Device Receives CE Mark for Use in Intermediate-Risk Patients

Todd Neale

August 01, 2016

News Daily News

微创二尖瓣腱索替换术前景看好，但还有很长的路要走

Shelley Wood

July 20, 2016

News Daily News

Minimally Invasive Mitral Valve Chordal Replacement Procedure Promising, but It’s Still Early Days

Shelley Wood

July 20, 2016

News Daily News

La Intervención de Sustitución Mínimamente Invasiva de las Cuerdas de la Válvula Mitral es Prometedora pero está en su Infancia

Shelley Wood

July 20, 2016

News Daily News

欧盟更快速核准医疗器械导致更多的安全警告和产品召回

Shelley Wood

July 05, 2016

Advertisement

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

TCTMD’s Top 10 Most Popular News and Features for 2016

Device Performance in Pre-Approval Studies vs Unrestricted Real-World Use: Lessons Learned and Future Opportunities

Key Note Lecture II. Regulatory Reform of Medical Device Approvals by the European Commission Motivating Factors, Anticipated Changes, and Timelines

La FDA Aprueba el Oclusor del FOP Amplatzer para la Prevención de ACV Recurrentes

FDA 批准 PFO 封堵器用于预防中风复发

FDA Approves Amplatzer PFO Occluder for Prevention of Recurrent Stroke

Corindus Vascular Robotics Receives FDA Clearance for Next Generation Robotic System

FDA Approves 34-mm TAVR Valve for Patients With Larger Anatomy

Sapien 3 Approved for Use in Intermediate-Risk Patients in Europe

FDA Expands Indications for Two Endovascular Stroke Therapies

TAVR as an Option for Intermediate-Risk Patients: Physicians Respond

Survival Better, No ‘Risk Creep’ for TAVR vs Surgery in Lower-Risk Patients

FDA Declines to Approve Portola’s Reversal Agent for Factor Xa Inhibitors

FDA Approves Sapien XT and Sapien 3 for Intermediate-Risk Patients

Next-Generation CoreValve Device Receives CE Mark for Use in Intermediate-Risk Patients

微创二尖瓣腱索替换术前景看好，但还有很长的路要走

Minimally Invasive Mitral Valve Chordal Replacement Procedure Promising, but It’s Still Early Days

La Intervención de Sustitución Mínimamente Invasiva de las Cuerdas de la Válvula Mitral es Prometedora pero está en su Infancia

欧盟更快速核准医疗器械导致更多的安全警告和产品召回

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content